MedTrace Logo

Using Pleural Effusions to Diagnose Cancer

NCT03319472 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 439

Last updated 2019-12-10

No results posted yet for this study

Summary

Pleural effusions (PE) are common conditions that signal either infection or cancer. The investigators aim to develop, validate, and prospectively assess the MAPED score, a clinical score that predicts malignancy at admission. This tool will assist clinicians all over the world to rapidly assess the probability of an effusion being malignant within 4 hours of admission.

Conditions

  • Pleural Effusion

Sponsors & Collaborators

  • University of Patras

    lead OTHER

Principal Investigators

  • Georgios T Stathopoulos, MD, PhD · Associate Professor of Physiology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-21
Primary Completion
2017-11-21
Completion
2018-11-21

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03319472 on ClinicalTrials.gov